ACRS•benzinga•
HC Wainwright & Co. Upgrades Aclaris Therapeutics to Buy, Maintains Price Target to $20
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on December 23, 2024 by benzinga